Arthritis & Rheumatology

1. Arthritis Rheumatol21 Nov 2022

   Peripheral Blood DNA Methylation–Based Machine Learning Models for Prediction of Knee Osteoarthritis Progression: Biologic Specimens and Data From the Osteoarthritis Initiative and Johnston County Osteoarthritis Project

   Diagnostic or prognostic studyOsteoarthritis

2. Arthritis Rheumatol19 Nov 2022

   Both Disease Activity and HLA–B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients

   Cross-sectional studySpondyloarthritis & PsA

3. Arthritis Rheumatol11 Nov 2022

   A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

   Randomized controlled trialLupus & APS

4. Arthritis Rheumatol11 Nov 2022

   Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II , Randomized, Double‐Blind , Placebo‐Controlled Trial

   Randomized controlled trialLupus & APS

5. Arthritis Rheumatol11 Nov 2022

   Genicular Nerve Block for Pain Management in Patients With Knee Osteoarthritis: A Randomized Placebo‐Controlled Trial

   Randomized controlled trialOsteoarthritis

6. Arthritis Rheumatol8 Nov 2022

   American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

   Guideline or statementAcross diseases

7. Arthritis Rheumatol23 Oct 2022

   American College of Rheumatology/ EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision

   Randomized controlled trialRA

All 607 Briefs in ExploreShowing Briefs 601–607 of 607, newest first